| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |